Study on Single and Multiple Atomization Inhalation of HRS-9821 Suspension for Inhalation in Healthy Subjects and COPD Patients

NCT05622864 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

106

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: HRS-9821
DRUG: HRS-9821

Sponsor

Guangdong Hengrui Pharmaceutical Co., Ltd